Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.

MLA

Skibola CF, et al. “Tumor Necrosis Factor (TNF) and Lymphotoxin-Alpha (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium.” American Journal of Epidemiology, vol. 171, no. 3, Feb. 2010, pp. 267–76. EBSCOhost, https://doi.org/10.1093/aje/kwp383.

APA

Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM, Cerhan JR, Skibola DR, Purdue M, Kane E, Lan Q, Foretova L, Schenk M, Spinelli JJ, Slager SL, De Roos AJ, Smith MT, Roman E, Cozen W, & Boffetta P. (2010). Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. American Journal of Epidemiology, 171(3), 267–276. https://doi.org/10.1093/aje/kwp383

Chicago

Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM, Cerhan JR, et al. 2010. “Tumor Necrosis Factor (TNF) and Lymphotoxin-Alpha (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium.” American Journal of Epidemiology 171 (3): 267–76. doi:10.1093/aje/kwp383.